North America Glycomics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Glycomics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Glycomics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Glycomics Market Regional Analysis

6.2 North America Glycomics Market Revenue 2020-2028 (US$ Million)

6.3 North America Glycomics Market Forecast Analysis

7. North America Glycomics Market Analysis – by Product

7.1 Enzymes

7.1.1 Overview
7.1.2 Enzymes: North America Glycomics Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Instruments

7.2.1 Overview
7.2.2 Instruments: North America Glycomics Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Kits

7.3.1 Overview
7.3.2 Kits: North America Glycomics Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.4 Reagents

7.4.1 Overview
7.4.2 Reagents: North America Glycomics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. North America Glycomics Market Analysis – by Application

8.1 Drug Discovery and Development

8.1.1 Overview
8.1.2 Drug Discovery and Development: North America Glycomics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Diagnostics

8.2.1 Overview
8.2.2 Diagnostics: North America Glycomics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Immunology

8.3.1 Overview
8.3.2 Immunology: North America Glycomics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.4 Cancer

8.4.1 Overview
8.4.2 Cancer: North America Glycomics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. North America Glycomics Market Analysis – by End User

9.1 Pharmaceutical & Biotechnology Companies

9.1.1 Overview
9.1.2 Pharmaceutical & Biotechnology Companies: North America Glycomics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Academic & Research Institutes

9.2.1 Overview
9.2.2 Academic & Research Institutes: North America Glycomics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Contract Research Organizations

9.3.1 Overview
9.3.2 Contract Research Organizations : North America Glycomics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. North America Glycomics Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Glycomics Market Breakdown, by Key Country, 2023 and 2028 (%)
10.2.1.1 North America Glycomics Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Glycomics Market Breakdown, by Product
10.2.1.1.2 US: North America Glycomics Market Breakdown, by Application
10.2.1.1.3 US: North America Glycomics Market Breakdown, by End User

10.2.1.2 Canada: North America Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Glycomics Market Breakdown, by Product
10.2.1.2.2 Canada: North America Glycomics Market Breakdown, by Application
10.2.1.2.3 Canada: North America Glycomics Market Breakdown, by End User

10.2.1.3 Mexico : North America Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Glycomics Market Breakdown, by Product
10.2.1.3.2 Mexico : North America Glycomics Market Breakdown, by Application
10.2.1.3.3 Mexico : North America Glycomics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Agilent Technologies, Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bruker Corporation

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 MERCK KGaA

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 New England Biolabs

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 S-BIO (Sumitomo Bakelite Co., Ltd.)

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Shimadzu Corporation

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Takara Bio Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Thermo Fisher Scientific Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Waters Corporation

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Glycomics Market

Analysis – by Product (Enzymes, Instruments, Kits, and Reagents), Application (Drug Discovery and Development, Diagnostics, Immunology, Cancer, and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations)